4.4 Million Americans Have Gotten Updated COVID Boosters
FRIDAY, Sept. 23, 2022 (HealthDay News) — At least 4.4 million Americans have received the updated COVID-19 booster shot.The U.S. Centers for Disease Control and Prevention posted the count Thursday as public health experts decried President Joe Bide…
Learn MoreBlood Clot Risk Remains Higher Almost a Year After COVID
FRIDAY, Sept. 23, 2022 (HealthDay News) — An increased risk of blood clots persists for close to a year after a COVID-19 infection, a large study shows. The health records of 48 million unvaccinated adults in the United Kingdom suggest that the pande…
Learn MoreMore Batches of Moderna COVID-19 Shots Shipped Amid Reports of Shortages
THURSDAY, Sept. 22, 2022 (HealthDay News) — To keep up with demand for updated booster shots, U.S. health officials are shipping out more batches of the revamped Moderna vaccine to pharmacies across the country.While supplies of the updated Pfizer bo…
Learn MoreCanada May Soon Drop COVID-19 Vaccine Requirement for International Travelers
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — The COVID-19 vaccine requirement for foreign nationals in Canada is likely to be eliminated by the end of September, the Associated Press reported, citing an official close to the matter who was not author…
Learn MorePerformance of COVID-19 Rapid Antigen Tests With Nasal Self-Sampling Examined
WEDNESDAY, Sept. 19, 2022 (HealthDay News) — During the period of omicron emergence, the performance of COVID-19 rapid antigen tests with nasal self-sampling declined, according to a study published online Sept. 14 in The BMJ.Ewoud Schuit, Ph.D., fro…
Learn MoreCanada May Soon Drop COVID Vaccine Requirement for International Travelers
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — If you haven’t had a COVID vaccine, you can’t travel to Canada, but that could change soon.The vaccine requirement for foreign nationals in that country is likely to be eliminated by the end of September, …
Learn MoreBebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
MONDAY, Sept. 19, 2022 (HealthDay News) — For high-risk patients with mild-to-moderate COVID-19 during the omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infecti…
Learn More¿Qué medicamentos funcionan mejor contra la COVID? La OMS actualiza las directrices de tratamiento
VIERNES, 16 de septiembre de 2022 (HealthDay News) — En una directriz que se actualizó el jueves, la Organización Mundial de la Salud (OMS) desaconseja ahora utilizar los medicamentos de anticuerpos sotrovimab y casirivimab-imdevimab en los pacientes…
Learn MoreLa COVID parece aumentar el riesgo de enfermedad de Alzheimer
VIERNES, 16 de septiembre de 2022 (HealthDay News) — Las infecciones con la COVID-19 podrían elevar de forma significativa el riesgo de una persona mayor de desarrollar la enfermedad de Alzheimer, sugiere un nuevo estudio de gran escala.Las personas …
Learn MoreLa OMS afirma que el final de la pandemia quizá esté cerca
JUEVES, 15 de septiembre de 2022 (HealthDay News) — El final de la pandemia de COVID-19 está a la vista, declaró el miércoles el líder de la Organización Mundial de la Salud (OMS), ya que las muertes están en su nivel más bajo en todo el mundo desde …
Learn More